Voltar à classificação

Mettler-Toledo International Inc (MTD)

Superavaliada
HealthcareDiagnostics & ResearchSwitzerland

Fundamental

62

Preço

$1486.44

Capitalização de Mercado

$30.96B

Parte 1 · Quanto vale a empresa

Visão Geral

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment. In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom. The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs; food manufacturers and retailers; chemical, specialty chemicals, and cosmetics companies; transportation and logistics, metals, and electronics industries; and academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 19 de setembro de 2026 with claude-haiku-4-5 — shared with all users

P/E: 36.3Score: 68Market cap: $250.91B

Thermo Fisher supplies the same laboratory customers with overlapping lines of analytical instruments, pipettes and process analytics, and competes for the large multi-year supply contracts of pharmaceutical and biotech labs.

P/E: 33.9Score: 72Market cap: $49.40B

Agilent competes for the same analytical-chemistry budget in pharmaceutical and industrial quality-control labs, with chromatography, spectroscopy and lab software that substitute for Mettler-Toledo's analytical instruments.

P/E: 109.6Score: 61Market cap: $43.52B

Waters sells chromatography, mass spectrometry and thermal-analysis systems to the same regulated pharmaceutical and materials laboratories where Mettler-Toledo places its thermal analysis and titration instruments.

P/E: 39.3Score: 65Market cap: $159.81B

Through its life-sciences and diagnostics brands Danaher bids for the same laboratory and bioprocessing equipment, consumables and service contracts, often bundling them across global accounts.

Sartorius AGNot tracked

Sartorius is the closest head-to-head rival in laboratory weighing, selling analytical and precision balances, pipettes and lab consumables to the same pharmaceutical, chemical and academic laboratories.

Shimadzu Corporation (島津製作所)Not tracked

Shimadzu builds balances, moisture analyzers and analytical instruments for the same industrial and laboratory customers, and is the main rival for Mettler-Toledo in Japan and much of Asia.

Balanço & Liquidez

Receita

$4.13B

Últimos 12 meses (até 30/06/2026)

Resultado Líquido

$906M

Últimos 12 meses (até 30/06/2026)

Fluxo de Caixa Livre

$849M

Capital Próprio Total

$-24M

Passivo Total

$3.74B

Rácio de Liquidez

1.12

Cobertura de Juros

-

Dívida/EBITDA

1.66

Resultados Por Ação

Receita & Resultado Líquido

Fluxo de Caixa Livre

Decomposição dos Resultados

Demonstração histórica

Margens ao longo do tempo

A dívida ao longo do tempo

Quanto pesa a dívida

Grelha do crescimento

Crescimento — Receitas

Estimativa de Valor Justo

Caso geralSobrevalorizada

Valor Justo

$1181.36

Preço Atual

$1486.44

Margem de Segurança

-25.8%

Intervalo de Valor Justo

$820.70 - $1542.03

Dispersão entre os métodos de avaliação utilizados, não um intervalo de confiança calibrado estatisticamente.

Métodos de Estimativa

Preço-alvo dos analistas:$1457.50
Fluxo de caixa descontado (DCF):$809.83
Multiplicador de lucros (P/E):$1446.10
Fórmula de crescimento de Graham:$1191.86
Valor da capacidade de gerar lucro (EPV):$386.72
P/B justificado:$236.18
Desconto de dividendos (Gordon):Dados insuficientes para o calcular
P/FFO, fundos de operações:Dados insuficientes para o calcular
Lucros de meio de ciclo:Dados insuficientes para o calcular
Multiplicador sobre as receitas:$807.64
Consenso dos Analistas:Comprar (10B / 9H / 0S)
Última Surpresa de Resultados:+5.18%

Métricas de Avaliação

Rácio P/E

34.06

ROE

-3677.4%

Rácio P/B

2360.93

P/FCF

35.04

Margem Bruta

60.3%

ROIC

-

Radar de Rentabilidade

Criação de Valor (Vantagem Competitiva)

ROIC

-

WACC

10.6%

ROIC − WACC

-

Critérios de Análise Fundamental

Aprovado (17)

  • EPS shows upward trend
  • EPS CAGR 12.37%
  • Price CAGR 11.95%
  • Gross Margin 60.3%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 1816.3%
  • Revenue Growth 5Y 5.5%
  • Analyst Consensus 53% Buy
  • Earnings Surprise avg 3.4%
  • Earnings Quality (OCF/NI) 1.08
  • Share Dilution -3.1%
  • Net Margin Trend 21.9% vs 21.5%
  • Piotroski F-Score 6/9

Reprovado (6)

  • P/FCF 35.04
  • P/B Ratio 2360.93
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • PEG Ratio 3.05

Indisponível (5)

  • ROIC NaN%
  • Dividend Payout NaN%
  • Debt/Equity ratio
  • Operating Margin NaN%
  • Interest Coverage

Piotroski F-Score

6/9

Sinais mistos: algumas áreas requerem atenção

score
criteria

Qualidade dos Resultados

1.08

Alta qualidade: resultados respaldados por caixa

Diluição de Ações

-3.1%

A recomprar ações. Favorável ao acionista

Participações institucionais

Governação

Equipa Executiva

NomeCargoIdade
Mr. Patrick K. KaltenbachPresident & CEO62
Mr. Shawn P. VadalaChief Financial Officer56
Ms. Susan Graham-BryceChief Human Resources Officer49
Mr. Marc de La GueronniereHead of European & North American Market Organizations61
Mr. Richard WongHead of Asia/Pacific59
Mr. Markus KoepfliChief Information Officer-
Mr. Adam William UhlmanHead of Investor Relations-
Ms. Michelle M. RoeChief Legal Officer & Corporate Secretary54
Mr. Oliver WittorfHead of Product Inspection, Retail & Global Supply Chain49
Mr. Gerhard KellerHead of Process Analytics56

Risco de Auditoria

2

Risco do Conselho

1

Risco de Remuneração

6

Risco dos Direitos dos Acionistas

5

Parte 2 · O preço e o momento de entrar

Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.

Documentos

  • Relatório anual (10-K)

    Uma visão anual do negócio, dos resultados financeiros e dos riscos da empresa.

    Arquivado em 2026-02-06

    Ver documento
  • Relatório trimestral (10-Q)

    Uma atualização sobre o desempenho financeiro dos últimos três meses.

    Arquivado em 2026-07-31

    Ver documento
  • Relatório de fato relevante (8-K)

    Um aviso sobre um fato relevante, como uma mudança na liderança ou um grande anúncio.

    Arquivado em 2026-08-03

    Ver documento

via SEC EDGAR

Histórico de Resultados

via SEC EDGAR

Latest News

Recent headlines for MTD, sourced from Markets Gazette.

No recent news for MTD.